baber/WOPTO huggingface dataset:
Patent AU-718522-B2 (AU)
Title: A process for the production of a condensation product of a carboxylic acid
Inventor: EYAL AHARON M
IPC: C07C235/06
Filed: 1997-02-21
Granted: 2000-04-13
Abstract: The invention provides a process for the production of a condensation product selected from the group consisting of an amide and an ester of a carboxylic acid from an organic compound selected from the group consisting of organic compounds carrying a hydroxyl group and organic compounds carrying an amine group and from a concentrated medium resulting from fermentation, said medium containing a salt of said acid, said salt being selected from the group consisting of a sodium salt, a calcium salt and mixtures thereof and said medium being at a pH of at least the pKa of said acid, said process comprising reacting said medium with said organic compound and with CO2, whereby said condensation product and a salt selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and mixtures thereof are formed; and, separating said condensation product from the reaction mixture formed in the previous step.
Patent AU-621321-B2 (AU)
Title: Bidentate conjugate and method of use thereof
Inventor: HARRIS PAUL C
IPC: G01N33/531
Filed: 1988-09-30
Granted: 1992-03-12
Abstract: A novel bidentate conjugate has two different chemical moieties, or bidentate members, attached through an adequate spacer moiety. Each bidentate member acts as a small molecule ligand and is capable of specifically binding to a different macromolecular substance. The bidentate members are relatively small molecules, usually less than about 7,000 Daltons in size. The spacer moiety is selected so that both bidentate members can simultaneously bind to their respective specific binding partners. Where the specific binding partners are multivalent, large complexes can be formed. The formation of these complexes can be inhibited by the presence of an unconjugated monovalent bidentate member, such as free analyte from a test sample. The bidentate is of particular use in turbidimetric or nephelometric inhibition immunoassay procedures.
Patent AU-752243-B2 (AU)
Title: Electrosurgical sphincter treatment apparatus
Inventor: EDWARDS STUART D
IPC: A61B18/14
Filed: 1999-02-19
Granted: 2002-09-12
Abstract: An apparatus treats tissue at or near a sphincter. The apparatus has an elongated member having at least one lumen including an inflation lumen, and a basket assembly including a first and a second arm. An inflatable member is coupled to the inflation lumen and has a deployed and a non-deployed state. In the deployed state, the inflatable member expands the basket assembly into contact with tissue. At least one of the first and second arms of the basket assembly has a fluid lumen having an aperture for conveying a fluid from the basket assembly. A source of fluid is coupled to the fluid lumen for conveyance of fluid through the aperture. The fluid can be, e.g., an electrolytic solution, and/or an anti-infection agent, and/or an echogenic media, and/or a steroid, and/or an anesthetic, and/or a medicament, and/or a tissue cooling agent. The source can be a drug delivery device.
Patent AU-719929-B2 (AU)
Title: Multiple epitope fusion protein
Inventor: VALENZUELA PABLO D T
IPC: C12P21/04
Filed: 1997-05-23
Granted: 2000-05-18
Abstract: Multiple copy epitope immunoassays are produced by: (1) identifying nucleotide sequences that encode a plurality of different epitopes; (2) placing the nucleotide sequences into an expression cassette wherein at least two copies of a sequence coding for the same epitope, preferably from different strains of a pathogen, are placed in the cassette; (3) transforming a suitable host with the cassette in order to express the sequences encoding the epitopes; (4) purifying the expressed epitopes; and (5) coating the epitopes on a surface of a substrate. The purified epitopes are encompassed by the general structural formula (A)x-(B)y-(C)z which represents a linear amino acid sequence, B is an amino acid sequence of an epitope or cluster of epitopes and each B contains at least five and not more than 1,000 amino acids, y is an integer of 2 or more, A and C are each independently an amino acid sequence of an epitope or cluster of epitopes not adjacent to B in nature and x and z are each independently an integer of 0 or more wherein at least one of x and z is 1 or more. The epitopes of the invention are more soluble than and are therefore more easily purified than conventional epitopes. Further, the presence of repeating epitope sequences (repeating at least B in the same linear amino acid sequence from different strains of a pathogen) increases the sensitivity and specificity of the assay. Repeated epitope sequences in a single linear antigen also decreases masking problems and makes it possible to include a greater number of epitopes on a unit area of substrate thereby improving sensitivity in the detection of antibodies.
Patent AU-659714-B2 (AU)
Title: High performance, durable, low-E glass and method of making same
Inventor: LINGLE PHILIP J
IPC: G02B5/28
Filed: 1993-02-19
Granted: 1995-05-25
Abstract: A high performance, durable, low-E glass exhibiting about 80% or more visible transmittance, a hemispherical emissivity (Eh) of about 0.13 or less, and a normal emissivity (En) of about 0.10 or less is formed by sputter-coating a layer system on the glass substrate which comprises an undercoat and overcoat of Si3N4, at least one silver layer, and at least two sandwiching layers of a nickel or nickel alloy, preferably with the nickel alloy being nichrome, and the chromium being in the form of a nitride thereof. <IMAGE>
Patent AU-621358-B2 (AU)
Title: Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
Inventor: HARPER JEFFREY W
IPC: C12N1/21
Filed: 1989-03-20
Granted: 1992-03-12
Abstract: Site-specific mutagenesis of a gene for angiogenin producing DNA sequences encoding mutant proteins having increased angiogenic activity are disclosed. Expression vectors containing these sequences are introduced into host cells and direct the production of the mutant angiogenic proteins with markedly increased angiogenic and ribonucleolytic activity. Replacement of a single amino acid, the aspartic acid at or corresponding to position 116 of angiogenin, with another amino acid including asparagine, alanine or histidine, yields mutant proteins with 8 to 15 fold increased ribonucleolytic activity toward tRNA and rRNA and 10 to 100 fold increased angiogenic potency in the chorioallantoic membrane assay. The mutant angiogenin proteins of this invention are useful therapeutic compositions to promote the development of a hemovascular network in a mammal or to promote wound healing, in particular, healing of torn or traumatized fibrocartilage material.
Patent AU-764062-B2 (AU)
Title: Displacement machine for compressible media
Inventor: KOESTERS HEINER
IPC: F04C18/16
Filed: 2000-05-16
Granted: 2003-08-07
Abstract: Shafts (3) for rotors (4) are driven by dedicated electric motors (6). The angular positions of these shafts are determined with synchro resolvers to help synchronize the rotors electronically. The shafts are fitted with gearwheels (7) for emergency synchronization. One or more gearwheels connect to the rotor for its shaft's resolver and to the shaft but can detached.
Patent AU-688979-B2 (AU)
Title: Analyte detection strip with orientation index
Inventor: PATEL HARSHAD I
IPC: G01N21/78
Filed: 1995-09-07
Granted: 1998-03-19
Abstract: A test strip is provided for determining the presence or quantity of an analyte in a liquid by inserting the strip into an optical reading apparatus. The test strip is provided with an orientation index zone having a reflectance that contrasts with the reflectance of areas contiguous thereto and such orientation index zone is employed to affirm that the test strip has not been inserted upside down with respect to the apparatus.
Patent AU-617631-B2 (AU)
Title: Optically active piperazine derivative
Inventor: NOHIRA HIROYUKI
IPC: C07D295/084
Filed: 1989-08-07
Granted: 1991-11-28
Abstract: A novel (-)-optically active piperazine derivative of the formula:   <CHEM> (wherein the mark of * indicates an optically active carbon) shows an increased cerebral circulation-improving effect as well as an enhanced safety.
Patent AU-776645-B2 (AU)
Title: Pregelatinized starch in a controlled release formulation
Inventor: VANDECRUYS ROGER PETRUS GEREBE
IPC: A61K47/48
Filed: 2000-03-24
Granted: 2004-09-16
Abstract: The present invention concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose.
Patent AU-772115-B2 (AU)
Title: Treatment of intracellular infection
Inventor: PASECHNIK VLADIMIR ARTYMOVICH
IPC: A61K47/48
Filed: 2000-04-10
Granted: 2004-04-08
Abstract: An agent for combating an intracellular microbial infection comprises a phage component and, associated therewith, a targeting moiety which directs the agent to a target cell and initiates delivery of the phage into the target cell. Once inside the target cell, the phage causes lysis of a microorganism residing within the target cell. A mycobacteriophage is combined with a targeting moiety of transferrin. Compositions comprising the agent, methods of preparing said agent, and use of said agent for combating intracellular infections are also provided.
Patent AU-686099-B2 (AU)
Title: Mammalian melanocyte stimulating hormone receptors and uses
Inventor: CONE ROGER D
IPC: C12Q1/68
Filed: 1993-04-07
Granted: 1998-02-05
Abstract: The present invention relates to a mammalian melanocyte stimulating hormone receptor (MSH-R). The invention is directed toward the isolation, characterization and pharmacological use of a mammalian melanocyte stimulating hormone receptor, the gene corresponding to this receptor, a recombinant eukaryotic expression construct capable of expressing a mammalian melanocyte stimulating hormone receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize mammalian melanocyte stimulating hormone receptor. The invention also provide methods for screening MSH-R agonists and antagonists in vitro using preparations of receptor from such cultures of eukaryotic cells transformed with a recombinant eukaryotic expression construct comprising the MSH-R receptor gene. The invention specifically provides human and mouse MSH-R genes.
Patent AU-680196-B2 (AU)
Title: Wool dyeing utilizing controlled dye addition
Inventor: HOLFELD WINFRIED THOMAS
IPC: D06P3/14
Filed: 1993-05-13
Granted: 1997-07-24
Abstract: A process for the dyeing of a fibrous article containing wool with an anionic dye and products processed thereby. The process includes immersing the article in a dyeing bath of a liquid solvent for the anionic dye. The liquid solvent and the article are heated to a temperature at least equal to the dyeing transition temperature. At least a portion of the dye is added as a miscible liquid concentrate while the solvent and the article are up to temperature. Stirring of the bath during the dye addition period and while the solvent and article are up to temperature is done to mix the dye concentrate with the solvent to form a dilute dye solution and to provide a flow of the dilute dye solution relative to the article to cause, on the average, essentially uniform dye transport of the anionic dye to the article. The dye addition rate is adjusted so that the dye addition rate is the primary control over the rate of dye uptake by the article.
Patent AU-668983-B2 (AU)
Title: Methods and compositions to monitor and control termites
Inventor: THORNE BARBARA L
IPC: A01P7/04
Filed: 1993-09-07
Granted: 1996-05-23
Abstract: The present invention provides compositions and methods of monitoring for termites and a method of controlling termites if infestation has occurred that utilizes the natural foraging and other social behaviors of the termite to collect and distribute a bait formulation that is preferred by termites.
Patent AU-780991-B2 (AU)
Title: Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
Inventor: WYNN THOMAS A
IPC: A61P9/00
Filed: 2000-04-28
Granted: 2005-04-28
Abstract: Methods are provided for treating or inhibiting the formation of tissue fibrosis using IL-13 antagonists, including without limitation soluble forms of the IL-13 receptor.
Patent AU-773272-B2 (AU)
Title: Universal ejection tool
Inventor: CHIARI MAURO
IPC: B26F1/40
Filed: 2000-07-26
Granted: 2004-05-20
Abstract: Ejection tool for cutting wastes comprises a frame (2) made of two identical plates (10,12) separated by lateral and transversal bars (3,4). There are separating band (17) placed between the plate to maintain their shape. The plates are bored at regular intervals, with the holes (11) of each plate facing each other. Pins (30) are passing two facing holes.
Patent AU-666409-B2 (AU)
Title: Process for applying chemical papermaking additives from a thin film to tissue paper
Inventor: AMPULSKI ROBERT STANLEY
IPC: A47K7/00
Filed: 1993-08-20
Granted: 1996-02-08
Abstract: Disclosed is a process for making soft tissue paper which includes providing a dry tissue web and then applying a sufficient amount of a chemical papermaking additive from a thin film to the dry web. The chemical papermaking additives are added to the surface of the tissue paper to enhance properties of the paper such as strength, softener, absorbency, and/or aesthetics. The chemical papermaking additive application process includes the steps of diluting the chemical papermaking additive with a suitable solvent, applying the diluted chemical solution to a heated transfer surface, evaporating the solvent from the dilute solution to form a film, and then transferring the film to the tissue by contacting the dry tissue web with the heated transfer surface. Preferably, the tissue web is dried to a moisture level below its equilibrium moisture content before application of the papermaking additive.
Patent AU-752873-B2 (AU)
Title: Pressure-sensitive removable adhesives based on polyacrylates, preparation process and articles containing them
Inventor: JONGE JOHAN DE
IPC: C09J133/04
Filed: 1999-07-21
Granted: 2002-10-03
Abstract: The present invention relates to pressure-sensitive removable adhesives based on polyacrylates, characterized in that they comprise a compound of formula:wherein R1, R2 and R3, which are identical or different, represent a linear or branched C1-C8, preferably C2-C6, alkyl radical; and R4 represents H or an acyl radical COR5 wherein R5 is a linear or branched C1-C3 alkyl radical. The present invention also relates to a process for the preparation of said adhesives. The present invention further relates to adhesive labels and tapes comprising said adhesives.
Patent AU-784758-B2 (AU)
Title: Cross-linked collagen matrices and methods for their preparation
Inventor: NOFF MATITIAU
IPC: C07K1/00
Filed: 2001-04-17
Granted: 2006-06-08
Abstract: A method for preparing cross-linked collagen and cross-linked collagen products. The method includes incubating collagen in a solution including water, at least one polar solvent and at least one sugar, to form cross-linked collagen. The solution may include a buffer having a suitable pH and ionic strength. The method may include removing excess unreacted sugar(s) and polar solvent(s) by washing the cross-linked collagen or by other methods. The method may also include dehydrating the cross-linked collagen, and may include subjecting the cross-linked collagen to critical point drying, or subjecting the collagen to drying or freeze-drying prior to cross-linking. The collagen may be prepared from atelopeptide collagen to reduce antigenicity, but may also be prepared from other suitable collagen types. The concentration and type of the polar solvent(s), the concentration and type of the reducing sugar(s), and the incubation duration may be varied to control the degree of cross-linking. The cross-linked collagen product may be in the form of a wet or dry matrix or membrane or may be suspended in a liquid in the form of an injectable preparation. The method may be applied to collagenous proteins and collagen-like peptides.
Patent AU-770308-B2 (AU)
Title: Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
Inventor: LIU LI
IPC: A61K31/165
Filed: 1999-10-14
Granted: 2004-02-19
Abstract: There is disclosed a pharmaceutical composition for the treatment of neoplasia, comprising a pharmaceutically acceptable carrier and a compound selected by: determining the cyclooxyegenase (COX) inhibitory activity of the compound; determining the PDE inhibition activity of the compound wherein the PDE is characterized by: (a) cGMP specificity over cAMP; (b) positive cooperative kinetic behaviour in the presence of cGMP substrate; (c) submicromolar affinity for cGMP; and (d) insensitivity to incubation with purified cGMP-dependent protein kinase; and selecting the compound that has COX inhibitory activity lower than said PDE activity for treating neoplasia. Also provided by the invention is a method for selecting a compound the treatment of neoplasia, comprising determining the cyclooxygenase (COX) inhibitory activity of the compound; determining the PDE2 inhibition activity of the compound; and selecting the compound that has COX inhibitory activity lower than said PDE activity for treating neoplasia.
Patent AU-766794-B2 (AU)
Title: Floor or wall covering from ceramics, wood, plastic, natural or artificial stone, and a tile or panels used for the same
Inventor: HASECKE GUIDO
IPC: F21Y101/00
Filed: 2001-03-20
Granted: 2003-10-23
Abstract: The floor wall covering made from ceramics, wood, plastic, natural or artificial stone, has at least one inlay illuminated with optical waveguides. A tile or panel inlay is illuminated by light from the optical waveguide. At least one recess ( 12 ) is provided in the floor or wall covering in which a tile or panel inlay is inserted. The tile or panel inlay is made of transparent material or made of a diffuse reflecting fiber or made of diffused reflecting fiber optical elements and in the optical waiveguide directs light from a remote source to the inlay.
Patent AU-528425-B2 (AU)
Title: Imidazo-and pyrimido-pyridoindoles
Inventor: GABOR
IPC: C07D471/14
Filed: 1980-01-15
Granted: 1983-04-28
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LU, NL, SE. Imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P9,F1  wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxygroup, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 . 1. Claim for the Contracting State : AT A process for preparing imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P11,F3 wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxy group, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 , characterized in that a compound of formula (II)  see diagramm : EP0015786,P11,F4  is reacted with an amine R2 NH2 , then the intermediate compound obtained, of formula (III)  see diagramm : EP0015786,P12,F1  is cyclized by means of formaldehyde in 30% aqueous solution, and, when R4 = H, the corresponding compound (I) may be alkylated to yield a compound (I) wherein R4 is alkyl.
Patent AU-704661-B2 (AU)
Title: A device for assembly and electrical connection of modular apparatuses such as circuit breakers or similar
Inventor: BARTOLO WILLIAM
IPC: H02B1/20
Filed: 1996-06-05
Granted: 1999-04-29
Abstract: The arrangement serves a circuit-breaker (3), a controller (8) and a single-pole and neutral switch (9) assembled to the same rail (2) with auxiliary triggering and signalling units (4,5). The switching equipment is interconnected and/or supplied by a bus-bar (12) comprising parallel bars (14) extending along the rail and at right angles to one face (50) of the housing. Each contact stud (e.g. 40a) of the switching equipment is connected selectively to one of the bars by a double knife-edge or double gripper, one end of which cooperates with the contact studs and the other end with the bars.
Patent AU-720407-B2 (AU)
Title: Optically pure (-) norcisapride for treating digestive tract disorders
Inventor: MCCULLOUGH JOHN R
IPC: A61K31/496
Filed: 1996-05-17
Granted: 2000-06-01
Abstract: Methods are disclosed utilizing the optically pure (-) isomer of norcisapride. This compound is a potent drug for the treatment of gastro-esophageal reflux disease, emesis, dispepsia and other conditions while substantially reducing the concomitant liability of adverse effects associated with cisapride. The (-) isomer of norcisapride also avoids the adverse drug interactions associated with racemic cisapride and other therapeutic agents.
Patent AU-768441-B2 (AU)
Title: Method for treating fertilizer process solutions
Inventor: KARONEN JANNE
IPC: C05B11/10
Filed: 2000-07-06
Granted: 2003-12-11
Abstract: A method for manufacturing a solid product containing nitrogen and phosphor, particular a solid ammonium phosphate and/or urea ammonium phosphate product, in which method the solution containing urea and phosphoric acid is heated. Water then evaporates from the solution and the urea in the solution decomposes into ammonia and carbon dioxide. The carbon dioxide exits the reactor together with water vapor; the generated ammonia neutralizes the phosphoric acid. A suspension containing ammonium phosphate and/or urea ammonium phosphate is obtained, which is solidified, dried, crushed, ground and/or granulated. The end product as such can be used as a fertilizer or it can be used as part of a mixed fertilizer.
Patent AU-678816-B2 (AU)
Title: Socket for electrical devices; particularly tubular elongated lamps, such as double-based fluorescent lamps and/or starters therefor
Inventor: MEWS HANS-PETER
IPC: H01R4/24
Filed: 1994-04-19
Granted: 1997-06-12
Abstract: In the case of a socket (1) for electrical equipment, at least one contact spring arrangement (49) is located in a housing (2) made of insulating material, in the case of which contact spring arrangement a contact spring tongue (51) for the cap pins, which are to be inserted, of the electrical equipment is integrally connected, via a connecting piece (52), to an insulation-piercing terminal contact (53). <IMAGE>
Patent AU-530678-B2 (AU)
Title: Phosphono-hydroxy-acetic acid
Inventor: LIEB FOLKER
IPC: C07F9/38
Filed: 1980-09-18
Granted: 1983-07-28
Abstract: The invention relates to phosphono-hydroxyacetic acid and salts thereof of Formula I as defined hereinabove, useful as antiviral agents, e.g. antiherpes agents. Also included in the invention are pharmaceutical compositions and medicaments containing said compounds of Formula I as the active ingredients as well as methods for the use of said compounds, compositions and medicaments.